Arya, Divya
Khan, Tarannum
Margolius, Adam J.
Fernandez, Hubert H.
Funding for this research was provided by:
NIH/NINDS (Research Support)
Article History
First Online: 16 August 2019
Compliance with Ethical Standards
:
: Divya Arya, Tarannum Khan, and Adam J. Margolius each declare no potential conflicts of interest. Hubert H. Fernandez has received research support from Acorda Therapeutics, Michael J. Fox Foundation, Movement Disorders Society, NIH/NINDS, Parkinson Study Group, Sunovion, but has no owner interest in any pharmaceutical company. Dr. Fernandez has received honoraria from American Osteopathic Association, Cleveland Clinic, South Alabama Medical Science Foundation Thoraxx Clinical Communications, UMA Education, as a speaker in CME events. Dr. Fernandez has received honoraria from Acorda Therapeutics, Denali Therapeutics, Pfizer, Partners Healthcare System(Parkinson Study Group), Sunovion Research and Development Trust as a consultant. Elsevier as the Editor-In-Chief of Parkinsonism and Related Disorders Journal. Dr. Fernandez has received royalty payments from Demos Publishing and Springer for serving as a book author/editor. The Cleveland Clinic has a contract with Teva for Dr. Fernandez’ role as a Co-Principal Investigator in SD-809/Austedo Tardive Dyskinesia global studies. Dr. Fernandez also serves as a member of the publication committee for Acorda Pharmaceuticals, Sunovion Pharmaceuticals but does not receive any personal compensation for this.
: This article does not contain any studies with human or animal subjects performed by any of the authors.